Výsledky vyhledávání - "Aude Roborel de Climens"

Akademický článek

Perspectives of patients with advanced or metastatic non-small cell lung cancer on symptoms, impacts on daily activities, and thresholds for meaningful change: a qualitative research study

Autor: Anna Cardellino, Manasee Shah, Jennifer Hanlon, Kimberly Kelly, Alexandra Martin, Aude Roborel de Climens, Sara Taiyari, Alexander Stojadinovic

Publikováno v: Frontiers in Psychology, Vol 14 (2023)

IntroductionAdvanced or metastatic non-small cell lung cancer (NSCLC) is associated with significant symptom burden. It is important to understand the impact of these disease-and treatment-related symptoms on patients’ daily lives and explore from

Externí odkaz: https://doaj.org/article/0ab1f00694454f7f91a498d427b2e2ec

Zobrazit plný text záznamu

Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers

Autor: Jean-François Yale, Aude Roborel de Climens, Naresh Aggarwal, Terry Dex, Hertzel C. Gerstein, Stewart Harris, Irene Hramiak, John Stewart, Lawrence A. Leiter

Publikováno v: Diabetes Therapy. 14:377-386

For people with type 2 diabetes mellitus who do not achieve glycated hemoglobin A1C targets after treatment with basal insulin therapies, additional therapy with a glucagon-like peptide-1 receptor agonist (GLP-1 RA) may be required. One option is to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71a6478ed9d8e760bf3d36f1afca0f67
https://doi.org/10.1007/s13300-022-01353-6

Zobrazit plný text záznamu

813-P: Treatment Satisfaction and Health Status in People with T2D Treated with Insulin Glargine 300 U/mL (Gla-300) : Patient-Reported Outcomes (PRO) from ATOS Study

Autor: NIAZ KHAN, AMIR TIROSH, ANIL BHANSALI, HERNANDO VARGAS-URICOECHEA, STEWART B. HARRIS, AUDE ROBOREL DE CLIMENS, MARIA AILEEN N. MABUNAY, MATHIEU COUDERT, VALERIE PILORGET, GAGIK R. GALSTYAN

Publikováno v: Diabetes. 71

Patients' satisfaction is a key determinant of treatment adherence and persistence, for optimal management of T2D. ATOS, a 12-month prospective observational study conducted in Asia, Middle East, North Africa, Latin America, and Eastern Europe, showe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1b444601c829d210c89ef185146b0501
https://doi.org/10.2337/db22-813-p

Zobrazit plný text záznamu

Living with Stargardt disease: insights from patients and their parents

Autor: Aude Roborel de Climens, Carla Dias Barbosa, Catherine Brun-Strang, Ronald Buggage, Béatrice Tugaut

Publikováno v: Ophthalmic Genetics. 42:150-160

Background: Stargardt disease (STGD), a rare, inherited macular degeneration most commonly affecting children and young adults, is a rapidly progressive disease leading to severe central vision los...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f92a7c49966ef84d404ae5974d39c436
https://doi.org/10.1080/13816810.2020.1855663

Zobrazit plný text záznamu

Understanding Reasons for Treatment Discontinuation, Attitudes and Education Needs Among People Who Discontinue Type 2 Diabetes Treatment: Results from an Online Patient Survey in the USA and UK

Autor: Alka Shaunik, Emilie Pain, Aude Roborel De Climens, Anders H. Boss

Publikováno v: Diabetes Therapy

Introduction Type 2 diabetes mellitus (T2DM) requires long-term treatment to achieve and maintain glycaemic control; however, up to 50% of people with T2DM discontinue treatment by 1 year. It is therefore important to understand the patient perspecti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d147ff13a802c76ca51675ea6e4b79d2
https://doi.org/10.1007/s13300-020-00843-9

Zobrazit plný text záznamu

Plný text ve formátu HTML

Patient‐reported outcomes in adults with type 1 diabetes in global real‐world clinical practice: the SAGE study

Autor: Grégory Bigot, Zsolt Bosnyak, Lori Berard, Emma G. Wilmot, Luis Eduardo Calliari, Daniela Bruttomesso, F. Javier Ampudia-Blasco, Anne L. Peters, Jochen Seufert, Dubravka Jurišić-Eržen, Eric Renard, Aude Roborel de Climens, Kelly L. Close

Publikováno v: Diabetes, Obesity and Metabolism
Diabetes, Obesity and Metabolism, Wiley, 2021, 23 (8), pp.1892-1901. ⟨10.1111/dom.14416⟩
Diabetes, Obesity and Metabolism, 2021, 23 (8), pp.1892-1901. ⟨10.1111/dom.14416⟩

International audience; Aims: This secondary analysis of the SAGE study aimed to evaluate the association between glycaemic control and patient-reported outcomes (PROs), in adults with type 1 diabetes (T1DM) across different age groups and regions.Ma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1763bf708cc1f8afe57783b01384ef3f
https://hal.archives-ouvertes.fr/hal-03218691

Zobrazit plný text záznamu

Development and First Use of the Patient’s Qualitative Assessment of Treatment (PQAT) Questionnaire in Type 2 Diabetes Mellitus to Explore Individualised Benefit–Harm of Drugs Received During Clinical Studies

Autor: Amy Findley, My-Liên Nguyên-Pascal, Aude Roborel de Climens, Matthew Reaney, Catherine Brun-Strang, Adam Gater, Kate Burrows

Publikováno v: Drug Safety

Introduction Individualised benefit–harm assessments can help identify patient-perceived benefits and harms of a treatment, and associated trade-offs that may influence patients’ willingness to use a treatment. This research presents the first us

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e76ee33f29712e377a1d9c1f0a387b47
http://europepmc.org/articles/PMC7007419

Zobrazit plný text záznamu

Take Control: A randomized trial evaluating the efficacy and safety of self‐ versus physician‐managed titration of insulin glargine 300 U/mL in patients with uncontrolled type 2 diabetes

Autor: Elías Delgado, Aude Roborel de Climens, Luiza Popescu, Krzysztof Strojek, Hans A. Frandsen, George Dimitriadis, Bernd Schultes, Melanie J. Davies, Mireille Bonnemaire, Arnaud Dauchy, David Russell-Jones

Publikováno v: Diabetes, Obesity & Metabolism
Scopus
RUO. Repositorio Institucional de la Universidad de Oviedo
instname

Aim To compare the efficacy and safety of self‐ versus physician‐managed titration of insulin glargine 300 U/mL (Gla‐300) in people with inadequately controlled type 2 diabetes. Methods Take Control (EudraCT number: 2015‐001626‐42) was a 24

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c412d1bd43071d362b669f467b000da5
https://doi.org/10.1111/dom.13697

Zobrazit plný text záznamu

2192-PUB: Treatment Satisfaction in People with Type 2 Diabetes (T2D) Receiving Basal Insulin (BI): Results from Real-World Studies and Randomized Controlled Trials (RCTs) with Insulin Glargine 300 U/mL (Gla-300)

Autor: Jukka Westerbacka, Luigi Meneghini, Stewart B. Harris, Aude Roborel De Climens, Frank J. Snoek, Felipe Lauand, Kamlesh Khunti

Publikováno v: Diabetes. 69

BI analogs can help optimize glycemic control in people with T2D, but the patients’ satisfaction is key for acceptance and treatment adherence. ACHIEVE, REACH, and REGAIN were open-label real-world studies comparing Gla-300 with standard of care BI

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::04657d78881195845379d401d3f6def1
https://doi.org/10.2337/db20-2192-pub

Zobrazit plný text záznamu

2232-PUB: Reasons for Treatment Discontinuation in Type 2 Diabetes (T2D): Results from an Online Patient Survey in the UK and U.S

Autor: Emilie Pain, Aude Roborel De Climens, Anders H. Boss, Alka Shaunik

Publikováno v: Diabetes. 69

T2D is a chronic condition that requires long-term treatment to achieve and maintain glycemic control. However, up to 50% of people with T2D discontinue treatment by 1 year. To better understand why this occurs, an online questionnaire was presented

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7f6fc7937f3a34e07d31235254f968e1
https://doi.org/10.2337/db20-2232-pub

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání